Category Archives: cross contamination

Research – Levels and types of microbial contaminants in different plant-based ingredients used in dairy alternatives

Science Direct

Abstract

In this study levels and types of microbial contaminants were investigated in 88 different plant-based ingredients including many that are used to manufacture dairy alternatives. Studied ingredients encompassed samples of pulses (pea, faba bean, chickpea, and mung bean), cereals/pseudocereals (oat, rice, amaranth and quinoa) and drupes (coconut, almond and cashew). The microbial analysis included: i) total viable count (TVC), ii) total aerobic mesophilic spore count (TMS), iii) heat resistant aerobic thermophilic spore count (HRTS), iv) anaerobic sulfite reducing Clostridium spore count (SRCS), and v) Bacillus cereus spore count (BCES). Microorganisms isolated from the counting plates with the highest sample dilutions were identified using 16S rRNA and MALDI-TOF MS analyses.

Many of the investigated ingredients showed a high proportion of spores as part of their total aerobic mesophilic counts. In 63 % of the samples, the difference between TVC and TMS counts was 1 Log10 unit or less. This was particularly the case for the majority of pea isolates and concentrates, faba bean isolates, oat kernels and flakes, and for single samples of chickpea isolate, almond, amaranth, rice, quinoa, and coconut flours. Concentrations of TVC ranged between <1.0 and 5.3 Log10 CFU/g in different samples, and TMS varied between <1.0 and 4.1 Log10 CFU/g. Levels of HTRS, BCES and SRCS were generally low, typically around or below the LOD of 1.0 Log10 CFU/g.

In total, 845 individual bacterial colonies were isolated belonging to 33 different genera. Bacillus licheniformis and B. cereus group strains were most frequently detected among Bacillus isolates, and these species originated primarily from pea and oat samples. Geobacillus stearothermophilus was the main species encountered as part of the HRTS. Among the Clostridium isolates, Clostridum sporogenes/tepidum were predominant species, which were mostly found in pea and almond samples. Strains with potential to cause foodborne infection or intoxication were typed using the PCR-based method for toxin genes detection. In the B. cereus group, 9 % of isolates contained the ces gene, 28 % contained hbl, 42 % cytK, and 69 % were positive for the nhe gene. Absence of the boNT-A and -B genes was confirmed for all isolated C. sporogenes/tepidum strains. Nearly all (98 %) B. licheniformis isolates were positive for the lchAA gene.

Insight into the occurrence of microbial contaminants in plant-based ingredients, combined with knowledge of their key inactivation and growth characteristics, can be used for the microbial risk assessment and effective design of plant-based food processing conditions and formulations to ensure food safety and prevent spoilage.

USA – FDA Alerts Parents and Caregivers to Cronobacter Safety Concerns with Crecelac Goat Milk Infant Formula Imported and Distributed by Dairy Manufacturers Inc.

FDA

Cerecelac Powdered Infant Formula

Cerecelac Powdered Infant Formula

Farmalac Powdered Infant Formula

Farmalac Powdered Infant Formula

What’s New

July 31, 2024

After conducting an abbreviated nutrient analysis of Crecelac Infant Powdered Goat Milk Infant Formula, the FDA found both elevated levels of potassium and chloride and low levels of Vitamin A. The potassium and chloride levels were significantly above the levels permitted in infant formula in the U.S. and could lead to kidney and/or heart problems if the infant formula is used for an extended period of time. In addition, low Vitamin A intake could lead to vision loss from a Vitamin A deficiency if the infant formula is used for an extended period of time.

As this product was part of a voluntary recall that the company initiated on May 24, 2024, all caregivers should have already disposed of the product and discontinued use. If you have continued to use this product, the FDA recommends discontinuing any further use. Parents and caregivers who used this product and have concerns should consult with their health care providers.

Audience

  • Parents and caregivers of infants who consume infant formula.

Summary of Problem and Scope

The FDA has determined that the infant formula products listed above were sold in the U.S. illegally because, among other things, the company has not submitted to the FDA the required premarket notification.

On May 21, 2024, the FDA recommended that the firm recall the infant formula products to which the firm agreed. As the FDA continued its investigation, the agency identified Cronobacter in a sample of the recalled Crecelac infant formula product. The FDA notified Dairy Manufacturers Inc. of these findings and they agreed to update their recall press release to include the laboratory results.

The FDA is continuing to work with the firm and its distributors to ensure the recall is effectively executed.

Further Information for Consumers

The FDA is issuing this advisory because infants that consume these products could be at risk of potentially severe infection due to the Cronobacter contamination. The FDA advises parents and caregivers not to feed these infant formula products to infants under their care. If your infant is experiencing symptoms related to Cronobacter infection, such as poor feeding, irritability, temperature changes, jaundice, grunting breaths, or abnormal body movements, contact your health care provider to report their symptoms and receive immediate care.

If caregivers are looking for an alternative goat milk infant formula for sale in the U.S., they may wish to speak with their infant’s health care provider, as there are goat milk infant formulas that either have completed the required FDA premarket notification process or are currently being marketed under the FDA’s enforcement discretion policy.

Additionally, parents and caregivers can find more information on safe infant feeding practices on the FDA’s infant formula landing page.

Recommendation for Consumers

To report a complaint or adverse event (illness or serious allergic reaction), you can:

Korea – E. coli Contamination Prompts Food Court Closure at Osan Air Base

Food Poisoning News

A routine inspection at Osan Air Base in South Korea has led to the closure of the base exchange food court after potential E. coli contamination was detected in a facility water line, according to Stars and Stripes. The base’s bioenvironmental engineering team conducted the test on Tuesday, with results confirming the presence of E. coli on Wednesday.

In response to the contamination, consumers were advised to boil or avoid using the water from building 965 for drinking, showering, bathing, and washing clothes. At present, it’s believed that no other buildings on the base are affected by the contamination.

Canada – Baby Gourmet Organic brand Banana raisin oatmeal organic whole grain baby cereal recalled due to Cronobacter spp.

Gov Canada

Product
Banana raisin oatmeal organic whole grain baby cereal
Issue
Food – Microbial Contamination – Other
What to do

Do not consume, use, sell, serve, or distribute recalled products

Distribution
National

The affected product is being recalled from the marketplace due to possible Cronobacter spp. contamination.

What you should do

  • If you think you became sick from consuming a recalled product, contact your healthcare provider
  • Check to see if you have recalled products
  • Do not consume, serve, use, sell, or distribute recalled products
  • Recalled products should be thrown out or returned to the location where they were purchased

Food contaminated with Cronobacter may not look or smell spoiled but can still make you sick. Although Cronobacter is not commonly linked to human illness, in rare cases it can cause serious or fatal infections. Cronobacter can cause rare bloodstream and central nervous system infections and has been associated with severe intestinal infection (necrotizing enterocolitis) and blood poisoning (sepsis), especially in newborns.

Research – Practices that Lead to Microbial Contamination of Milk in Zimbabwe’s Informal Dairy Sector

Food Safety.com

A recent study provided insight into the on-farm hygiene characteristics that affect the contamination of milk produced at informal dairy farms in Zimbabwe. The research was led by the Zimbabwe Ministry of Health and Childcare’s Department of Food and Microbiology, in collaboration with Midlands State University, the University of Venda, and the National Food Institute at the Technical University of Denmark.

Specifically, the study looked at the microbiological safety level profiles (MSLPs) of dairy workers’ hands and milking containers, and the influence of hygiene and handling practices on MSLPs of raw and cultured milk, from six informal dairy farms in Zimbabwe. Interviews and direct observations were conducted to assess hygiene and handling practices, and a total of 192 environmental swabs and milk samples were taken to be analyzed for the presence of microbes. The researchers sampled and swabbed raw milk, cultured milk, the dairy workers’ hands, and milking containers, which were analyzed for total bacterial and coliform counts, Escherichia coliSalmonellaListeria monocytogenes, and Klebsiella pneumonia.

Italy – PACK OF EGGS OF 6 (MAXI) – Microbial Contamination

Salute

Brand : AZIENDA AGRICOLA VANZELLI GINO

Name : PACK OF EGGS OF 6

Reason for reporting : Recall due to microbiological risk

Publication date : 23 June 2024

Documentation

Documentation

Italy – PACK OF EGGS OF 6 – Microbial Contamination

Salute

Brand : AZIENDA AGRICOLA VANZELLI GINO

Name : PACK OF EGGS OF 6

Reason for reporting : Recall due to microbiological risk

Publication date : 23 June 2024

Documentation

Documentation

France – Additional Batches – Sardine with olive oil and chili pepper – Bacterial Contamination

Gov France

Product category
Food
Product subcategory
Fishing and aquaculture products
Product brand name
Parmentier
Model names or references
Sardines Parmentier hand-canned “olive oil and chili” 135g Sardines Parmentier hand-canned “olive oil and chili” 135g in batches of 4
Product identification
GTIN Date
3019081238650 Minimum durability date 03/27/2029
3019089044680 Minimum durability date 03/27/2029
Packaging
/
Start/end date of marketing
From 05/24/2024 to 06/03/2024
Storage temperature
Product to be stored at room temperature
Health mark
PT C.241.1P CE
Further information
/
Geographical sales area
Whole France
Distributors
AUCHAN CARREFOUR INTERMARCHE LECLERC SYSTEM U

USA – FDA Alerts Parents and Caregivers to Cronobacter Safety Concerns with Crecelac Goat Milk Infant Formula Imported and Distributed by Dairy Manufacturers Inc.

FDA

Cerecelac Powdered Infant Formula

Cerecelac Powdered Infant Formula

Farmalac Powdered Infant Formula

Farmalac Powdered Infant Formula

Audience

  • Parents and caregivers of infants who consume infant formula.

Products

  • CRECELAC INFANT Powdered Goat-Milk Infant Formula with Iron 0 to 12 months – Net Wt. 12.4 oz (352g)
  • Farmalac BABY Powdered Infant Formula with Iron 0 to 12 months Net Wt. 12.4 oz (352g)
  • Farmalac BABY Powdered Infant Formula with Iron Low Lactose 0 to 12 months Net Wt. 12.4 oz (352g)

Products are being sold at some retail stores in Texas and, possibly, additional locations in the U.S.

The U.S. Food and Drug Administration (FDA) is alerting parents and caregivers about Cronobacter safety concerns with Crecelac Infant Powdered Goat Milk Infant Formula and other infant formula products imported and distributed by Dairy Manufacturers Inc. Although the company initiated a recall of the products referenced above on May 24, 2024, because they were not in compliance with all of the FDA’s infant formula regulations, the FDA is now issuing this safety alert due to new findings of Cronobacter contamination in a sample of Crecelac Infant Powdered Goat Milk Infant Formula. As part of its investigation into this matter, on May 29, 2024, the FDA found Cronobacter in a sample of Crecelac Infant Powdered Goat Milk Infant Formula collected from a retail store in Texas.

Separately, the FDA is also alerting parents and caregivers to a recall initiated by Dairy Manufacturers Inc. of the Farmalac products listed above because of their failure to meet U.S. infant formula regulations. Limited sampling of the Farmalac products did not detect Cronobacter; however, the firm has not submitted the required premarket notification to the FDA to demonstrate the safety and nutritional adequacy of the infant formula. The FDA is continuing to work with the firm and its distributors to ensure the recall is effectively executed.

Cronobacter is a bacterium that can cause bloodstream and central nervous system infections, such as sepsis and meningitis, respectively. Complications from Cronobacter infection in infants can include brain abscess, developmental delays, motor impairments, and death.

Symptoms of Cronobacter infection in infants may include poor feeding, irritability, temperature changes, jaundice, grunting breaths, or abnormal body movements.

At this time, the FDA is not aware of any illnesses associated with these products and the FDA does not anticipate any impact on the supply of infant formula based on the recall of these products.

Research – Long chain unsaturated fatty acids alter growth and reduce biofilm formation of Cronobacter sakazakii

Wiley Online

Cronobacter sakazakii is a foodborne pathogen predominately transmitted through contaminated dried foods and affects populations including neonates, infants, and the elderly. Following several recent outbreaks, it is now a notifiable infection in those under 12 months of age. Current control methods include strict manufacturing guidelines, with monitoring of this genus a legal requirement in powdered infant formula production. Fatty acids have long been known as antimicrobials, with long-chain fatty acids increasingly identified as agents that target virulence factors. This study gives insight into the changes promoted by three long-chain unsaturated fatty acids (oleic, linoleic, and α-linolenic) on C. sakazakii growth, morphology, and biofilm formation. Each fatty acid was individually introduced to C. sakazakii 29544 both as a sole carbon source and as an addition to complex media. Following comparison to the untreated control, bacterial cells treated with these fatty acids showed a significant and media-dependent impact on growth and biofilm inhibition. With further characterization, long-chain fatty acids, including α-linolenic acid, could be utilized as a control method with minimal safety constraints regarding their use in the food production environment.